119 related articles for article (PubMed ID: 3671393)
1. Effect of thromboxane A2-synthetase inhibitor OKY-046 and evening primrose oil (Efamol) on mercuric chloride induced autoimmune glomerulonephritis in Brown-Norway rats.
Papanikolaou N; Hatziantoniou C; Gkika EL
Prog Clin Biol Res; 1987; 242():43-9. PubMed ID: 3671393
[No Abstract] [Full Text] [Related]
2. Alteration of mercuric chloride-induced autoimmune glomerulonephritis in brown-Norway rats by herring oil, evening primrose oil and OKY-046 a selective TXA-synthetase inhibitor.
Papanikolaou N
Prostaglandins Leukot Med; 1987 May; 27(2-3):129-49. PubMed ID: 3475724
[TBL] [Abstract][Full Text] [Related]
3. [Effects of a selective thromboxane A2 synthetase inhibitor, OKY-046, on proteinuria of aminonucleoside nephrotic rats].
Suzuki S; Akama H; Kume K; Higuchi E; Kamiyama S; Suzuki J; Ohara N; Yugeta E; Kato K; Suzuki H
Nihon Jinzo Gakkai Shi; 1988 Apr; 30(4):341-6. PubMed ID: 3230687
[No Abstract] [Full Text] [Related]
4. Partial protection against acute renal failure by Efamol.
Papanikolaou N; Darlametsos J; Hatziantoniou C; Gkika E; Lefkos N; Stewart C; Horrobin D; Giannoulis K; Bariety J
Prog Clin Biol Res; 1989; 301():271-7. PubMed ID: 2798451
[No Abstract] [Full Text] [Related]
5. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
Niwa T; Nomura T; Ozawa Y; Maeda K; Shibata M
Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
[No Abstract] [Full Text] [Related]
6. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
Ohsugi S
Nihon Geka Hokan; 1986 Mar; 55(2):297-305. PubMed ID: 3827476
[No Abstract] [Full Text] [Related]
7. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
Shikano M; Ogawa K; Ito T; Chen LS; Ito Y; Imaizumi M; Uno T; Tsutsumi S; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():375-7. PubMed ID: 3159226
[No Abstract] [Full Text] [Related]
8. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
Niwa T; Maeda K; Shibata M; Yamada K
Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)--clinical study among multiple institutions].
Yonekawa Y; Handa H; Okamoto S; Ohta T; Kamijo Y; Oda Y; Kondo A; Nin K; Yamamoto T; Ban S
Nihon Geka Hokan; 1986 May; 55(3):473-84. PubMed ID: 3541826
[No Abstract] [Full Text] [Related]
10. The influence of dietary marine oil (Polepa) and evening primrose oil (Efamol) on prostaglandin production by the rat mesenteric vasculature.
Nassar BA; Manku MS; Huang YS; Jenkins DK; Horrobin DF
Prostaglandins Leukot Med; 1987 Mar; 26(3):253-63. PubMed ID: 3033691
[TBL] [Abstract][Full Text] [Related]
11. Effects of OKY-046 and nifedipine in cyclosporine-induced renal dysfunction in rats.
Papanikolaou N; Darlametsos I; Tsipas G; Morphake P; Bokas S; Gkikas G; Hornych A; Bariety J; Gkika EL; Karageorgou I; Patsialos K
Prostaglandins Leukot Essent Fatty Acids; 1996 Oct; 55(4):249-56. PubMed ID: 8951993
[TBL] [Abstract][Full Text] [Related]
12. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210
[No Abstract] [Full Text] [Related]
13. [Protective effect of a thromboxane synthetase inhibitor, OKY-046, in patients with acute respiratory failure].
Sakio H; Usui Y; Mita H; Onoda N; Iida M; Okuda C
Masui; 1984 Sep; 33(9):964-9. PubMed ID: 6542601
[No Abstract] [Full Text] [Related]
14. Evening primrose oil (Efamol) in the treatment of children with atopic eczema.
Bordoni A; Biagi PL; Masi M; Ricci G; Fanelli C; Patrizi A; Ceccolini E
Drugs Exp Clin Res; 1988; 14(4):291-7. PubMed ID: 3048953
[TBL] [Abstract][Full Text] [Related]
15. A long-term study on the use of evening primrose oil (Efamol) in atopic children.
Biagi PL; Bordoni A; Masi M; Ricci G; Fanelli C; Patrizi A; Ceccolini E
Drugs Exp Clin Res; 1988; 14(4):285-90. PubMed ID: 3048952
[TBL] [Abstract][Full Text] [Related]
16. Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats.
Cameron NE; Cotter MA; Robertson S
Diabetes; 1991 May; 40(5):532-9. PubMed ID: 2022301
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
Moriuchi M
Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
[No Abstract] [Full Text] [Related]
18. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs.
Chung KF; Aizawa H; Becker AB; Frick O; Gold WM; Nadel JA
Am Rev Respir Dis; 1986 Aug; 134(2):258-61. PubMed ID: 3509981
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic assessment of the evening primrose].
Szczesna M
Rocz Panstw Zakl Hig; 1993; 44(2-3):139-46. PubMed ID: 8016534
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of natural oils as sources of gamma-linolenic acid to correct peripheral nerve conduction velocity abnormalities in diabetic rats: modulation by thromboxane A2 inhibition.
Dines KC; Cotter MA; Cameron NE
Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):159-65. PubMed ID: 8931113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
